StockData
Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc. (JSPR) stock

JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$11.52+1.18 (+11.41%)

Close on Nov 18, 2026Market cap $383.32MP/E –Yield –

Jasper Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Jasper Therapeutics

Jasper Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Jasper Therapeutics figures

See a number that looks wrong?